Sections
Log in
Top News
U.S. News World News Featured Voices
Odd News
Entertainment
Movies Music TV
Sports
Soccer NFL NBA MLB NHL Golf Horse Racing Tennis Col. Football Col. Basketball
Photos
News Entertainment Sports Features Archives
More...
Defense Featured Science Health Archive Almanac
About Feedback
About Feedback
Search
Trending
9/11 fund
Payless
Theodore McCarrick
Jussie Smollett
Illinois shooting
Iran attack
Laurie Hernandez
'Alexa & Katie'
Nigeria election
Colin Kaepernick
Stephen Curry
YNW Melly
Health News
May 12, 2018 / 3:58 PM

Breaks from osteoporosis drugs linked to greater risk of fractures

By
HealthDay News

SATURDAY, May 12, 2018 -- Osteoporosis patients who take "holidays" from bisphosphonate drugs are at increased risk for fractures, a new study finds.

A six-year follow-up of patients who took a break from the bone-building drugs found 15 percent of them suffered fractures, according to researchers at Loyola University in Maywood, Ill.

"Fracture risk needs to be regularly assessed during the drug holiday and treatment resumed accordingly," said Dr. Pauline Camacho and her colleagues.

Bisphosphonates, such as alendronate (Fosamax) and risedronate (Actonel), are the most widely prescribed osteoporosis drugs. They are designed to slow or prevent bone loss.

RELATED Hair products used by black women may affect hormones

But patients who take these drugs for long periods are typically told to take temporary breaks to prevent rare but serious side effects to the jaw and thighs.

However, there is little data on how long these breaks should last, the researchers explained.

To shed light on the issue, they examined the medical records of patients (371 women, 30 men) with osteoporosis or osteopenia (weak bones but not osteoporosis). Patients took bisphosphonates for an average of 6.3 years before beginning breaks from the drugs.

RELATED U.S. seniors dying from falls at a higher rate

Over six years, 15.4 percent of the patients suffered fractures after going on their drug holiday. The most common fracture sites were the wrist, foot, ribs and spine. However, foot fractures are not currently considered osteoporosis-related fractures, the researchers noted.

The patients most likely to suffer fractures were older and had lower bone mineral density at the beginning of the study. Patients who suffered fractures were put back on bisphosphonates.

The yearly incidence of fractures ranged from about 4 percent to almost 10 percent, with most occurring during the fourth and fifth years.

RELATED Depression rates among youth in U.S. higher than ever

"Patients who begin drug holidays at high risk for fracture based on bone mineral density, age or other clinical risk factors warrant close follow-up during the holiday, especially as its duration lengthens," the researchers said in a university news release.

The study was published recently in Endocrine Practice.

More information

The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases has more on osteoporosis.

Copyright © 2018 HealthDay. All rights reserved.

Follow us on Facebook, Twitter and Instagram for more UPI news and photos.

Trending Stories

Number of push-ups men can do in a row may indicate heart health
More U.S. adults reporting chronic pain, study says
HPV unlikely to be spread by hands, researchers say
Study: Chemical in Roundup may increase cancer risk by 40 percent
Hip and knee replacements show high durability, study shows

Photo Gallery

 
Lunar New Year celebrations in Beijing

Latest News

Pentagon chief to review funds to shift for building border wall
On This Day: Geronimo dies as prisoner of war in Oklahoma
Almanac for Sunday, Feb. 17, 2019
Famous birthdays for Feb. 17: Joseph Gordon-Levitt, Michael Jordan
Nauert withdraws from U.N. ambassador consideration
 
Back to Article
/
Back to top
About UPI Contact Feedback Advertisements Submit News Tips
Copyright © 2019 United Press International, Inc. All Rights Reserved.
Terms of UsePrivacy Policy